Former Velsera GC Annabelle Newman Joins Sciensus as General Counsel & Group Company Secretary
Sciensus has strengthened its leadership team with the appointment of Annabelle Newman as General Counsel & Group Company Secretary. In her new role, Newman will lead the company’s legal, governance, and company secretarial functions, supporting the executive team and Board while ensuring robust frameworks across key European markets.
Newman brings over 25 years of experience in corporate legal leadership, governance, regulatory strategy, and enterprise risk. She joins Sciensus from senior roles at Velsera and Syneos Health, where she managed multinational legal teams and played a key role in large-scale transformation programs.
Commenting on her appointment, Newman said,
“I’m proud to join Sciensus, which has a compelling mission to improve patients’ lives by enabling access to medicines and specialist services. I look forward to supporting sustainable growth, strong governance and a culture grounded in integrity and patient focus.”
Christian Tucat, CEO of Sciensus, added:
“We are delighted to welcome Annabelle. Her experience and collaborative approach will be invaluable as we continue to grow, strengthen our governance, and innovate in how we support patients and partners.”
Throughout her career, Newman has demonstrated expertise in delivering commercially focused legal advice across complex environments. Her prior roles include Vice President and Assistant General Counsel, Head of EMEA Legal at Syneos Health, and General Counsel at Velsera. She began her career in corporate law with BG Group (a Royal Dutch Shell company), progressing from paralegal to legal counsel while advising on multinational asset governance, commercial contracts, and compliance.
In her role at Sciensus, Newman will support the company’s position as a trusted partner to pharmaceutical companies and healthcare organisations, overseeing legal and governance matters while enabling the company’s growth and innovation agenda.
Sciensus is an integrated, end-to-end commercialisation partner, helping healthcare providers and pharmaceutical companies deliver therapies more efficiently across Europe. Its services include compliant distribution, in-home clinical care, digital patient support, real-world data collection, and insights throughout the product lifecycle.
If you have a news or hire publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at [email protected] or call us on +91 8879634922.